Effect of hemodiafiltration on mortality, inflammation and quality of life

Hemodiafiltration - A New Era

Volumn , Issue , 2010, Pages 39-52

  den Hoedt, Claire H ^a,b   Mazairaca, Albert H A ^a   van den Dorpel, Marinus A ^b   Grooteman, Muriel P C ^c,d   Blankestijn, Peter J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Maasstad Hospital Rotterdam   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872177200     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783805595612.ch5     Document Type: Chapter

References (62)

1. Stel VS, Kramer A, Zoccali C, Jager KJ: The 2007 ERA-EDTA Registry Annual Report -a precis. NDT Plus 2009;2:514-521.
2. Vanholder R, Van LS, Glorieux G: The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity? J Nephrol 2008;21:146-160.
3. Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, Klassen P, Port FK: Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 2006;69:2087-2093.
4. Jirka T, Cesare S, Di BA, Perera CM, Ponce P, Richards N, Tetta C, Vaslaky L: Mortality risk for patients receiving hemodiafiltration versus hemodialysis. Kidney Int 2006;70:1524-1525.
5. Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, Rindi P, Donati G, Antonelli A, Panicucci E, Tripepi G, Tetta C, Palla R: Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transplant 2008;23:2337-2343.
6. Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K: Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol 2009;4:1944-1953.
7. Penne EL, Blankestijn PJ, Bots ML, van den Dorpel MA, Grooteman MP, Nube MJ, Ter Wee PM: Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport Study. Semin Dial 2005;18:47-51.
8. Van der Weerd NC, Penne EL, van den Dorpel MA, Grooteman MP, Nube MJ, Bots ML, Ter Wee PM, Blankestijn PJ: Haemodiafiltration: promise for the future? Nephrol Dial Transplant 2008;23:438-443.
9. Penne EL, van BT, van der Weerd NC, Grooteman MP, Blankestijn PJ: Optimizing haemodiafiltration: tools, strategy and remaining questions. Nephrol Dial Transplant 2009;24:3579-3581.
10. Ledebo I, Blankestijn PJ: Haemodiafiltration optimal efficiency and safety. NDT Plus 2010;3:8-16.
11. Blankestijn PJ, Ledebo I, Canaud B: Hemodiafiltration: clinical evidence and remaining questions. Kidney Int 2010;77:581-587.
12. Grooteman MP, Ter Wee PM, Blankestijn PJ, Bots ML, Dorpel MA, Nube MJ: Haemodiafiltration: an update. Eur Nephrol 2010 (in press).
13. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D: Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int 1999;55:286-293.
14. Penne EL, van der Weerd NC, Grooteman MP, Blankestijn PJ: Results from the RISCAVID study: is haemodiafiltration associated with improved survival? Nephrol Dial Transplant 2008;23:3034.
15. Wizemann V, Lotz C, Techert F, Uthoff S: On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study. Nephrol Dial Transplant 2000;15(suppl 1):43-48.
16. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La GG, Orlandini G: Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 1996;50:1293-1302.
17. Penne EL, Visser L, van den Dorpel MA, van der Weerd NC, Mazairac AH, van Jaarsveld BC, Koopman MG, Vos P, Feith GW, Kremer Hovinga TK, van Hamersvelt HW, Wauters IM, Bots ML, Nube MJ, Ter Wee PM, Blankestijn PJ, Grooteman MP:
18. Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Gronhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Suleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wuthrich RP, Gottlow M, Johnsson E, Zannad F: Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009;360:1395-1407.
19. Penne EL, Blankestijn PJ, Bots ML, van den Dorpel MA, Grooteman MP, Nube MJ, van der Tweel, I, Ter Wee PM: Effect of increased convective clearance by on-line hemodiafiltration on all-cause and cardiovascular mortality in chronic hemodialysis patients the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125]. Curr Control Trials Cardiovasc Med 2005;6:8.
20. Turkish HDF Study: Comparison of postdilution on-line hemodiafiltration and hemodialysis (h ttp://clinicaltrials.gov/ct2/ show/nct00411177), 2006.
21. Maduell F: Convection versus diffusion: Is it time to make a change? (in Spanish) Nefrologia 2009;29:589-593.
22. Canaud B, Morena M, Leray-Moragues H, Chalabi L, Cristol JP: Overview of clinical studies in hemodiafiltration: what do we need now ? Hemodial Int 2006;10(suppl 1):S5-S12.
23. Bolasco P, Altieri P, Andrulli S, Basile C, Di FS, Feriani M, Pedrini L, Santoro A, Zoccali C, Sau G, Locatelli F: Convection versus diffusion in dialysis: an Italian prospective multicentre study. Nephrol Dial Transplant 2003;18(suppl 7):vii50-vii54.
24. FINESSE Trial: Filtration in the neuropathy of end-stage kidney disease symptom evolution (h ttp://www.anzctr.org.au/trial_view. aspx?ID = 308240), 2009.
25. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O, Massy Z: Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008;3:505-521.
26. Carrero JJ, Yilmaz MI, Lindholm B, Stenvinkel P: Cytokine dysregulation in chronic kidney disease: how can we treat it? Blood Purif 2008;26:291-299.
27. Carrero JJ, Stenvinkel P: Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol 2009;4(suppl 1):S49-S55.
28. Tripepi G, Mallamaci F, Zoccali C: Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 2005;16(suppl 1): S83-S88.
29. Qureshi AR, Alvestrand A, Vino-Filho JC, Gutierrez A, Heimburger O, Lindholm B, Bergstrom J: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002;13(suppl 1):S28-S36.
30. Calabro P, Golia E, Yeh ET: CRP and the risk of atherosclerotic events. Semin Immunopathol 2009;31:79-94.
31. Snaedal S, Heimburger O, Qureshi AR, Danielsson A, Wikstrom B, Fellstrom B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Barany P: Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Am J Kidney Dis 2009;53:1024-1033.
32. Vaslaki LR, Berta K, Major L, Weber V, Weber C, Wojke R, Passlick-Deetjen J, Falkenhagen D: On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study. Artif Organs 2005;29:406-412.
33. Kuo HL, Chou CY, Liu YL, Yang YF, Huang CC, Lin HH: Reduction of pro-inflammatory cytokines through hemodiafiltration. Ren Fail 2008;30:796-800.
34. Tiranathanagul K, Praditpornsilpa K, Katavetin P, Srisawat N, Townamchai N, Susantitaphong P, Tungsanga K, Eiam-Ong S: On-line hemodiafiltration in Southeast Asia: a three-year prospective study of a single center. Ther Apher Dial 2009;13:56-62.
35. Filiopoulos V, Hadjiyannakos D, Metaxaki P, Sideris V, Takouli L, Anogiati A, Vlassopoulos D: Inflammation and oxidative stress in patients on hemodiafiltration. Am J Nephrol 2008;28:949-957.
36. Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, Ladanyi E, Fodor B, Stein G, Pischetsrieder M, Zima T, Wojke R, Gauly A, Passlick-Deetjen J: On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 2006;24:163-173.
37. Schiffl H: Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis. Eur J Med Res 2007;12:26-33.
38. Panichi V, Manca-Rizza G, Paoletti S, Taccola D, Consani C, Filippi C, Mantuano E, Sidoti A, Grazi G, Antonelli A, Angelini D, Petrone I, Mura C, Tolaini P, Saloi F, Ghezzi PM, Barsotti G, Palla R: Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs. online haemodiafiltration: a crossover randomized multicentre trial. Nephrol Dial Transplant 2006;21:756-762.
39. Panichi V, Rizza GM, Taccola D, Paoletti S, Mantuano E, Migliori M, Frangioni S, Filippi C, Carpi A: C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes. Biomed Pharmacother 2006;60:14-17
40. Seino Y, Ikeda U, Ikeda M, Yamamoto K, Misawa Y, Hasegawa T, Kano S, Shimada K: Interleukin-6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 1994;6:87-91.
41. Liu Y, Berthier-Schaad Y, Fallin MD, Fink NE, Tracy RP, Klag MJ, Smith MW, Coresh J: IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol 2006;17:863-870.
42. Zoccali C, Tripepi G, Mallamaci F: Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients? J Am Soc Nephrol 2006;17:S169-S173.
43. Carracedo J, Merino A, Nogueras S, Carretero D, Berdud I, Ramirez R, Tetta C, Rodriguez M, Martin-Malo A, Aljama P: On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: a prospective, crossover study. J Am Soc Nephrol 2006;17:2315-2321.
44. Mittal SK, Ahern L, Flaster E, Maesaka JK, Fishbane S: Self-assessed physical and mental function of haemodialysis patients. Nephrol Dial Transplant 2001;16:1387-1394.
45. Unruh ML, Weisbord SD, Kimmel PL: Health-related quality of life in nephrology research and clinical practice. Semin Dial 2005;18:82-90.
46. King MT, Fayers PM: Making quality-oflife results more meaningful for clinicians. Lancet 2008,371:709-710.
47. Testa MA, Simonson DC: Assessment of quality-of-life outcomes. N Engl J Med 1996;334:835-840.
48. Ware JE, Snow KK, Kosinski M, Gandek B: SF-36 Health Survey-Manual and Interpretation Guide. Boston, The Health Institute, New England Medical Center, 1993.
49. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB: Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 1994;3:329-338.
50. Liem YS, Bosch JL, Arends LR, Heijenbrok-Kal MH, Hunink MG: Quality of life assessed with the Medical Outcomes Study Short Form 36-Item Health Survey of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health 2007;10:390-397.
51. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL: Methods for the Economic Evaluation of Health Care Programmes, ed 3. Oxford, Oxford University Press, 2005.
52. Unruh M, Benz R, Greene T, Yan G, Beddhu S, DeVita M, Dwyer JT, Kimmel PL, Kusek JW, Martin A, Rehm-McGillicuddy J, Teehan BP, Meyer KB: Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study. Kidney Int 2004;66:355-366.
53. Altieri P, Sorba G, Bolasco P, Asproni E, Ledebo I, Cossu M, Ferrara R, Ganadu M, Cadinu F, Serra G, Cabiddu G, Sau G, Casu D, Passaghe M, Bolasco F, Pistis R, Ghisu T: Predilution haemofiltration -the Second Sardinian Multicentre Study: comparisons between haemofiltration and haemodialysis during identical Kt/V and session times in a long-term cross-over study. Nephrol Dial Transplant 2001;16:1207-1213.
54. Beerenhout CH, Luik AJ, Jeuken-Mertens SG, Bekers O, Menheere P, Hover L, Klaassen L, van der Sande FM, Cheriex EC, Meert N, Leunissen KM, Kooman JP: Pre-dilution online haemofiltration vs. low-flux haemodialysis: a randomized prospective study. Nephrol Dial Transplant 2005;20:1155-1163.
55. Moreno F, Lopez Gomez JM, Sanz-Guajardo D, Jofre R, Valderrabano F: Quality of life in dialysis patients. A Spanish multicentre study. Spanish Cooperative Renal Patients Quality of Life Study Group. Nephrol Dial Transplant 1996;11(suppl 2):125-129.
56. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W: A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 2000;11:2344-2350.
57. Lin CL, Huang CC, Chang CT, Wu MS, Hung CC, Chien CC, Yang CW: Clinical improvement by increased frequency of on-line hemodialfiltration. Ren Fail 2001;23:193-206.
58. Schiffl H: Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis. Eur J Med Res 2007;12:26-33.
59. De Wit GA, Ramsteijn PG, de Charro FT: Economic evaluation of end stage renal disease treatment. Health Policy 1998;44:215-232.
60. Ward RA, Greene T, Hartmann B, Samtleben W: Resistance to intercompartmental mass transfer limits β2-microglobulin removal by post-dilution hemodiafiltration. Kidney Int 2006;69:1431-1437.
61. Penne EL, van der Weerd NC, Blankestijn PJ, van den Dorpel MA, Grooteman MP, Nube MJ, Ter Wee PM, Levesque R, Bots ML: Role of residual kidney function and convective volume on change in β2-microglobulin levels in hemodiafiltration patients. Clin J Am Soc Nephrol 2010;5:80-86.
62. Himmelfarb J: Chronic kidney disease and the public health: gaps in evidence from interventional trials. JAMA 2007;297:2630-2633.